It has been shown that NLRP3 is elevated in patients with Alzheimer’s disease (39), viral encephalitis (40), MS (41), traumatic brain injury (42), stroke (43), Parkinson’s disease (44), epilepsy (45), and other diseases. Here, NLRP3 is linked to myeloid sarcoma.